Item type:Thesis, Open Access

Beiträge zur Entwicklung von potentiellen Inhibitoren gegen das apikoplastäre Ferredoxin-Ferredoxin-NADP(H)-Reduktase-System, sowie Hemmstoffen des eukaryotischen Initiationsfaktors 4A und der bakteriellen RNaseP Teil 1 und Teil 2 und 3

Thumbnail Image

Files

dems_teil1.pdf (8.78 MB)
dems_teil2.pdf (17.92 MB)

Date

2022-05-05

Authors

Publisher

Philipps-Universität Marburg
DOI

Supervisors

Abstract

Apicomplexan parasites are the reason for some severe diseases in mankind such as malaria or toxoplasmosis. For malaria infections the medical options are running shorter due to resistances. A cure for latent toxoplasmosis is not available yet. Thus, the need for new drugs against new targets is urgent. The first part of the thesis is about the development of compounds with inhibitory activity towards the apicomplexan ferredoxin-ferredoxin-NADP(H)-reductase system. This redox-system is essential in apicomplexan parasites like Plasmodium and Toxoplasma and seems to be a promising drug target. 83 compounds out of six structural classes were synthesized and their and the activity of 42 other compounds against Toxoplasma gondii Ferredoxin-NADP(H)-reductase was measured in a photometric enzyme-assay. Chosen compounds were also measured in a lactate-dehydrogenase assay against P. falc. in a cell-based assay. Promising structural classes are benzothiazole-derivatetives and thiazolidinone-derivatives, which were derived from a herbizide structure. The measurement of these compounds were able to give us a hint about structure-activity-relationships. As a complete new active class of inhibitory molecules propagylic alkohols were found. The second part of the thesis is about addressing a host target to fight viral diseases. Viruses like the Ebola Virus use the eukaryotic translational system to replicate itself. Silvestrol is a natural compound that inhibits the eukaryotic initiation factor 4A (eIF4A). Computer-supported we designed and subsequently synthesised 43 compounds out of four structural classes which were measured in a cell-based assay for their activity against eIF4A. Triazine derivatives were able to inhibit eIF4A in micromolar range, hydantoine derivates were found as activators of eIF4A – just like isosorbide-derivatives. The third part is about targeting RNase P a bacterial enzyme involved in tRNA maturation. Addressing this enzyme with an inhibitor successfully would give us a new class of antibiotics, that is so urgently needed. We were able to synthesise diacylthiosemicarbazides and diacylsemicarbazides to check their inhibitory activity.

Review

Metadata

Contributors
Supervisor:
Dates
Created: 2022Issued: 2022-05-05Updated: 2022-05-05
DOI
https://doi.org/10.17192/z2022.0107
Faculty
Fachbereich Pharmazie
Publisher
Philipps-Universität Marburg
Language
ger
Data types
DoctoralThesis
Keywords
EbolaToxoplasmosisAntibioticsMalariaMalariaToxoplasmoseAntibiotika
DFG-subjects
HelikaseeIF4AToxoplasma gondiiDrug designPlasmodiumApicomplexaRibozymFerredoxin-NADP(H)-ReduktaseFerredoxinRNase PEbola
DDC-Numbers
610
License
https://rightsstatements.org/vocab/InC-NC/1.0/
URI
https://open.uni-marburg.de/handle/10.17192/z2022.0107
show more
Schäfer, Eva-Maria: Beiträge zur Entwicklung von potentiellen Inhibitoren gegen das apikoplastäre Ferredoxin-Ferredoxin-NADP(H)-Reduktase-System, sowie Hemmstoffen des eukaryotischen Initiationsfaktors 4A und der bakteriellen RNaseP Teil 1 und Teil 2 und 3. : Philipps-Universität Marburg 2022-05-05. DOI: https://doi.org/10.17192/z2022.0107.

License

item.page.license.under-copyright
This item has been published with the following license: In Copyright